皮质兴奋性作为肌萎缩侧索硬化的预后与表型分层生物标志物
这项多中心回顾性研究纳入意大利16家三级中心的743例肌萎缩侧索硬化患者,分析上肢肌肉记录的MEP:CMAP比值与表型、分期及生存的关系。结果显示该比值在不同表型间差异显著,与King分期进展相关,且是独立的生存预测因素。
要点
- MEP:CMAP比值在不同ALS表型间差异显著,下运动神经元型、连枷型、经典型和延髓型以高兴奋性为主。
- 锥体束型和原发性侧索硬化以低兴奋性为主,低兴奋性随King分期进展而增加。
- 高兴奋性患者生存期更短,MEP:CMAP比值是独立的生存预测因素。
核心结论
- MEP:CMAP比值可作为ALS皮质兴奋性的可扩展生物标志物,具有跨表型和疾病分期的预后价值。
研究设计与样本
- 多中心回顾性研究,纳入意大利16家三级中心的743例肌萎缩侧索硬化患者。
- 分析上肢肌肉记录的MEP:CMAP比值,分为高兴奋性、正常和低兴奋性三类。
主要发现
- MEP:CMAP比值在不同表型间差异显著(p < 0.0001)。
- 高兴奋性患者生存期更短(p = 0.004),发病1年内检测亦如此(p = 0.006)。
- Cox回归显示MEP:CMAP比值是独立生存预测因素(HR 1.84,95%CI 1.12-3.03,p = 0.016)。
- 低兴奋性随King分期进展而增加(p < 0.0001)。
关键数值与推荐
- 表型分类包括进行性肌萎缩(或下运动神经元型)、连枷臂/腿型、经典型、延髓型、以上运动神经元体征为主型(或锥体束型)和原发性侧索硬化。
- 疾病分期采用King分期。
临床怎么用
- MEP:CMAP比值或可用于ALS患者的表型分层、疾病分期评估和生存预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite its clinical heterogeneity, amyotrophic lateral sclerosis is unified by early and prominent alterations in cortical excitability, increasingly recognized as contributors to disease progression. This study assessed whether the ratio between motor evoked potential (MEP) amplitude, reflecting upper motor neuron integrity, and compound muscle action potential (CMAP) amplitude, indexing lower motor neuron function, could provide an accessible marker of corticospinal excitability to stratify patients by phenotype, stage, and survival. METHODS: In this multicenter retrospective study, 743 amyotrophic lateral sclerosis patients from 16 tertiary centers in Italy were analyzed. The MEP:CMAP ratio, recorded from upper limb muscles, was categorized as hyperexcitable, normal, or hypoexcitable. Phenotypes included progressive muscular atrophy (or lower motor neuron), flail arm/leg, classic, bulbar, patient with predominant upper motor neuron signs (or pyramidal), and primary lateral sclerosis. Disease stage was assessed using King's staging. Survival was analyzed using Kaplan-Meier curves and Cox regression models. RESULTS: The MEP:CMAP ratio differed significantly across phenotypes (p < 0.0001), with hyperexcitability predominating in lower motor neuron, flail, classic, and bulbar forms, and hypoexcitability in pyramidal and primary lateral sclerosis. Hypoexcitability increased in advanced King's stages (p < 0.0001). Hyperexcitable patients had shorter survival (p = 0.004), including when tested within 1 year of onset (p = 0.006). Cox regression identified the MEP:CMAP ratio as an independent survival predictor (HR 1.84, 95% CI 1.12-3.03, p = 0.016). INTERPRETATION: This real-world study supports the clinical value of the MEP:CMAP ratio as a scalable biomarker of cortical excitability in amyotrophic lateral sclerosis, with prognostic relevance across phenotypes and disease stages. ANN NEUROL 2025;98:801-813.
引用
- Ranieri F, Senerchia G, Bonan L, et al. Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis. Ann Neurol. 2025. PMID: 40557915. doi:10.1002/ana.27305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。